COVID-19 vaccine, inactivated (Investigational)

Brand and Other Names:Covaxin
  • Print
Sections

Dosing & Uses

AdultPediatric

See Pediatric Dosing & Uses

COVID-19 Disease Prevention

EUA submitted to FDA for immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children aged 2-18 years

Next:

Pharmacology

Mechanism of Action

Whole-viron inactivated vaccine using Vero cell manufacturing platform (as has been used in production of inactivated polio vaccine for 35 years, as well as other traditional childhood vaccines)

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.